Committee Chairman Sen. Chuck Grassley, R-Iowa, and ranking member Sen. Ron Wyden, D-Ore., invited the following companies to attend:
- AbbVie
- AstraZeneca
- Bristol-Myers Squibb Co.
- Johnson & Johnson
- Merck & Co.
- Pfizer
- Sanofi
The Senate Finance Committee held an initial hearing on drug prices in January, during which Mr. Grassley denounced drug executives’ lack of attendance. The senators said some of these drug companies have been re-invited to the next hearing, although they did not say which.
More articles on pharmacy:
Despite controversies, J&J ranks among Fortune’s most-admired companies
Bristol-Myers swings to $1.2B profit in Q4
Bernie Sanders takes aim at drug’s $375K price tag
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.